» Articles » PMID: 11264157

Bone Marrow Transplantation Corrects Osteopetrosis in the Carbonic Anhydrase II Deficiency Syndrome

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2001 Mar 27
PMID 11264157
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Carbonic anhydrase II (CAII), found in renal tubules, brain, and osteoclasts, is critical in acid-base homeostasis and bone remodeling. Deficiency of CAII gives rise to a syndrome of osteopetrosis, renal tubular acidosis (RTA), and cerebral calcification with associated developmental delay. It is inherited in an autosomal recessive fashion and found most frequently in the Mediterranean region and the Middle East. We report 2 related Irish families with clinically severe CAII deficiency in whom the gene mutation has been fully elucidated. Two children, one from each family, have undergone allogeneic bone marrow transplantation because of severe progressive visual and hearing loss. The older 2 children had already developed cerebral calcification and marked visual loss at the time of diagnosis and were treated symptomatically. Post-transplantation evaluation at 2 and 3 years demonstrates histologic and radiologic resolution of their osteopetrosis with stabilization of hearing and vision. Both children remain developmentally delayed and continue to have RTA, and the older child has now developed cerebral calcification. Allogeneic bone marrow stem cell replacement cures the osteoclast component of CAII deficiency and retards the development of cerebral calcification, but it appears to have little or no effect on the renal lesions. (Blood. 2001;97:1947-1950)

Citing Articles

Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy.

Li B, Zhao X, Xie W, Hong Z, Cao Y, Zhang Y BMC Med Genomics. 2024; 17(1):134.

PMID: 38764052 PMC: 11103847. DOI: 10.1186/s12920-024-01906-7.


Blessing in disguise: when head trauma solves the riddle of carbonic anhydrase II deficiency.

Al Zubi Y, Al Sharie A, Dwairi W, Altamimi E Radiol Case Rep. 2022; 17(3):847-851.

PMID: 35035649 PMC: 8753056. DOI: 10.1016/j.radcr.2021.12.004.


Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.

Ghislat G, Rahman T, Ballester P Biomolecules. 2020; 10(11).

PMID: 33227945 PMC: 7699199. DOI: 10.3390/biom10111570.


Report of Another Mutation Proven Case of Carbonic Anhydrase II Deficiency.

Satapathy A, Pandey S, Chaudhary M, Bagga A, Kabra M, Uwe K J Pediatr Genet. 2019; 8(2):91-94.

PMID: 31061753 PMC: 6499615. DOI: 10.1055/s-0038-1675781.


Case update on cranial osteopetrosis: which is the role of the neurosurgeon?.

Stella I, Vinchon M, Guerreschi P, de Berranger E, Bouacha I Childs Nerv Syst. 2017; 33(12):2181-2186.

PMID: 28762040 DOI: 10.1007/s00381-017-3553-4.